[1]郑小鹏,辛 华.糖尿病肾病研究进展[J].医学信息,2018,(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
 ZHENG Xiao-peng,XIN Hua.Progress in the Study of Diabetic Nephropathy[J].Medical Information,2018,(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
点击复制

糖尿病肾病研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2018年16期
页码:
26
栏目:
综述
出版日期:
2018-08-15

文章信息/Info

Title:
Progress in the Study of Diabetic Nephropathy
文章编号:
1006-1959(2018)16-0026-05
作者:
郑小鹏辛 华
佳木斯大学,黑龙江 佳木斯 154000
Author(s):
ZHENG Xiao-pengXIN Hua
Jiamusi University,Jiamusi 154000,Heilongjiang,China
关键词:
糖尿病肾病发病机制细胞因子
Keywords:
Key words:Diabetic nephropathyPathogenesisCytokine
分类号:
R587.2
DOI:
10.3969/j.issn.1006-1959.2018.16.008
文献标志码:
A
摘要:
糖尿病肾病是目前糖尿病最为常见的并发症,一旦发病,则机体代谢变得毫无规律,极大地影响了人体正常机能。基于此本文凭借对糖尿病肾病的发病机制进行深入探析,最终总结出了下述结论:其发病机制主要受制于若干因素的影响,常见的有如下几种:糖代谢紊乱、肾脏血流改变,细胞因子表达异常,遗传因素以及氧化应激等。深入探究其发病机制,有助于确定最佳的根治方法。
Abstract:
Abstract:Diabetic nephropathy is the most common complication of diabetes,once the onset of disease,the body metabolism becomes irregular,greatly affecting the normal function of the human body.Based on this,this paper makes an in-depth analysis of the pathogenesis of diabetic nephropathy,and finally concludes the following conclusions:The pathogenesis is mainly affected by several factors,such as glucose metabolism disorders,renal blood flow changes,abnormal cytokine expression,genetic factors and oxidative stress.In-depth study of its pathogenesis is helpful to determine the best radical treatment.

参考文献/References:

[1]Mogensen CE,Christensen CK,Vittinghus E.The stages in diabetic renal disease:with emphasis on the stage of incipient diabetic nephropathy[J].Diabetes,1983,32(Supplement 2):64-78.
[2]Cho N H,David W,Guariguata L.IDF Diabetes Atlas Sixth edition[J].International Diabetes Federation,2014.
[3]Kawanami D,Matoba K,Utsunomiya K.Signaling pathways in diabetic nephropathy[J].Histol Histopathol,2016,31(10):1059-1067.
[4]ElGamal H,Munusamy S.Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy:Promises and Challenges[J].Protein Pept Lett,2017,24(1):71-77.
[5]Lewko B,Latawiec E,Maryn A,et al.Osmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes[J].Exp Diabetes Res,2011:278963.
[6]Jiang W,Li Z,Zhao W,et al.Breviscapine attenuatted contrast medium-induced nephropathy via PKC Akt MAPK signalling in diabetic mice[J].Am J Transl Res,2016,8(2):329-341.
[7]Moradi M,Rahimi Z,Amiri S,et al.AT1R A1166C variants in patients with type 2 diabetes mellitus and diabetic nephropathy[J].J Nephropathol,2015,4(3):69-76.
[8]Zain M,Awan FR.Renin Angiotensin Aldosterone System(RAAS):its biology and drug targets for treating diabetic nephropathy[J].Pak J Pharm Sci,2014,27(5):1379-1391.
[9]Toyama T,Shimizu M,Furuichi K,et al.Treatment and impact of dyslipidemia in diabetic nephropathy[J].Clin Exp Nephrol,2014,18(2):201-205.
[10]Chen G,Wang T,Uttarwar L,et al.SREBP-1 is a novel mediator of TGFβ1 signaling in mesangial cells[J].J Mol Cell Biol,2014,6(6):516-530.
[11]Xie S,Lu K,Zhang Y,et al.Effects of Jiangya Xiaoke prescription on TGF-β1 in diabetic nephropathy rats with hypertension and its mechanisms[J].Int J Clin Exp Med,2015,8(4):5129-5136.
[12]Van Krieken R,Chen G,Gao B,et al.Sterol Regulatory Element Binding Protein(SREBP)-1 is a novel regulator of the Transforming Growth Factor(TGF)-β receptor I(TβRI) through exosomal secretion[J].Cell Signal,2017,29(5):158-167.
[13]Wen D,Huang X,Zhang M,et al.Resveratrol attenuates diabetic nephropathy via modulating angiogenesis[J].PLoS One,2013,8(12):e82336.
[14]Patel L,Thaker A.The effects of adenosine A2B receptor inhibition on VEGF and nitric oxide axis-mediated renal function in diabetic nephropathy[J].Ren Fail,2014,36(6):916-924.
[15]Sun L,Kanwar YS.Relevance of TNF-α in the context of other inflammatory cytokines in the progression of diabetic nephropathy[J].Kidney Int,2015,88(4):662-665.
[16]Guo Y,Song Z,Zhou M,et al.Infiltrating macrophages in diabetic nephropathy promote podocytes apoptosis via TNF-α-ROS-p38MAPK pathway[J].Oncotarget,2017,8(32):53276-53287.
[17]Bondeva T,Wolf G.Reactive oxygen species in diabetic nephropathy:friend or foe[J].Nephrol Dial Transplant,2014,29(11):1998-2003.
[18]Yuan F,Liu YH,Liu FY,et al.Intraperitoneal administration of the globular adiponectin gene ameliorates diabetic nephropathy in Wistar rats[J].Mol Med Rep,2014,9(6):2293-2300.
[19]Zhu K,Kakehi T,Matsumoto M,et al.NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney[J].Free Radic Biol Med,2015,83(2):21-30.
[20]Tang ZH,Zeng F,Zhang XZ.Human genetics of diabetics nephropathy[J].Ren Fail,2015,37(3):363-371.
[21]McKnight AJ,Duffy S,Maxwell AP.Genetics of diabetic nephropathy:a long road of discovery[J].Curr Diab Rep,2015,15(7):41.

相似文献/References:

[1]刘 璐,秦新月.阿尔茨海默病患者血尿酸水平变化的研究[J].医学信息,2018,(02):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
 LIU Lu,QIN Xin-yue.Study on the Changes of Serum Uric Acid in Alzheimer 's Disease Patients[J].Medical Information,2018,(16):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
[2]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
 CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Medical Information,2018,(16):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[3]王玉霞.剖宫产术后子宫疤痕妊娠的临床诊治[J].医学信息,2018,(10):48.[doi:10.3969/j.issn.1006-1959.2018.10.015]
 WANG Yu-xia.Clinical Diagnosis and Treatment of Uterine Scar Pregnancy after Cesarean Section[J].Medical Information,2018,(16):48.[doi:10.3969/j.issn.1006-1959.2018.10.015]
[4]何丽杰.中西医治疗糖尿病肾病的临床效果分析[J].医学信息,2018,(10):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
 HE Li-jie.Clinical Effect Analysis of Diabetic Nephropathy Treated by Chinese and Western Medicine[J].Medical Information,2018,(16):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
[5]贺 伟,高 峰.24 h尿微量白蛋白、血清胱抑素C水平与血清肌酐、尿素水平在2型糖尿病肾病早期诊断的意义[J].医学信息,2018,(11):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
 HE Wei,GAO Feng.The Significance of 24 h Urinary Microalbumin,Serum Cystatin C and Serum Creatinine and Urea Levels in the Early Diagnosis of Type 2 Diabetic Nephropathy[J].Medical Information,2018,(16):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
[6]王煜婷.原发性痛经发病机制及口服药物治疗进展[J].医学信息,2018,(13):56.[doi:10.3969/j.issn.1006-1959.2018.13.016]
 WANG Yu-ting.Research Progress in Pathogenesis and Oral Medication of Primary Dysmenorrhea[J].Medical Information,2018,(16):56.[doi:10.3969/j.issn.1006-1959.2018.13.016]
[7]黄秋菊.胱抑素C及脂蛋白α在早期糖尿病肾病诊断中的价值研究[J].医学信息,2018,(14):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
 HUANG Qiu-ju.The Value of Cystatin C and Lipoprotein α in the Diagnosis of Early Diabetic Nephropathy[J].Medical Information,2018,(16):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
[8]陆新虹,温玉洁,胡 欣,等.α-硫辛酸对2型糖尿病肾病患者 血清内脂素的影响研究[J].医学信息,2018,(14):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
 LU Xin-hong,WEN Yu-jie,HU Xin,et al.Effect of α-lipoic Acid on Serum Visfatin in Patients with Type 2 Diabetic Nephropathy[J].Medical Information,2018,(16):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
[9]李志俊,王 利,王 浩.姜黄素改善糖尿病肾病的作用机制研究[J].医学信息,2018,(24):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
 LI Zhi-jun,WANG Li,WANG Hao.Study on the Mechanism of Curcumin in Improving Diabetic Nephropathy[J].Medical Information,2018,(16):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
[10]肖学秀.益气活血汤联合西药治疗早期糖尿病肾病的临床观察[J].医学信息,2019,(02):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
 XIAO Xue-xiu.Clinical Observation of Yiqi Huoxue Decoction Combined with Western Medicine in Treating Earlyn Diabetic Nephropathy[J].Medical Information,2019,(16):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]

更新日期/Last Update: 2018-08-15